Timothy Aaron Graubert

机构：Harvard University, Massachusetts General Hospital, Center for Cancer Research · ORCID：0000-0002-7710-1171

发表论文 309 篇 · 总被引 26032 次 · h-index 62

代表论文

• Results from paradigm - a phase 2 randomized multi-center study comparing azacitidine and venetoclax to conventional induction chemotherapy for newly diagnosed fit adults with acute myeloid leukemia (2025 · Blood · 被引 33)
• Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunity (2026 · Science · 被引 12)
• Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia (2026 · Journal of Clinical Oncology · 被引 4)
• OGFOD1 enables AML chemo- and nutrient stress resistance by regulating protein synthesis (2025 · Cell Metabolism · 被引 4)
• Integrative cytogenetic and molecular studies unmask “chromosomal mimicry” in hematologic malignancies (2025 · Blood Advances · 被引 4)
• Clinical Activity and Safety of the Oral ATR Inhibitor Ceralasertib (AZD6738) in Patients with MDS or CMML after Prior HMA Therapy (2024 · Blood · 被引 4)